De-masking oxytocin-deficiency in craniopharyngioma and assessing its link with affective function

Dorothea Gebert1, Matthias K Auer2, Mareike R Stieg2

  • 1Research Group Clinical Neuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany.

Psychoneuroendocrinology
|November 28, 2017
PubMed

Insights

Craniopharyngioma patients show normal baseline oxytocin, but blunted release after exercise. Reduced oxytocin is linked to hypothalamic damage and anxiety in these patients.

Area of Science:

  • Neuroendocrinology
  • Neuropsychology
  • Oncology

Background:

  • Craniopharyngioma (CP) frequently causes panhypopituitarism and diabetes insipidus, impacting neuropeptide function.
  • Oxytocin's roles in social behavior, mood, and anxiety suggest its relevance in CP patients with affective dysfunction.
  • Tumor-related damage to critical brain regions may impair oxytocin production and release.

Purpose of the Study:

  • To investigate oxytocin levels in adult patients with craniopharyngioma (CP).
  • To determine if altered oxytocin levels correlate with affective and emotional dysfunction in CP patients.
  • To assess oxytocin release in response to physical exercise as a stimulation method.

Main Methods:

  • Prospective study involving 26 adult CP patients and 26 matched healthy controls.
  • Measurement of baseline and exercise-stimulated salivary oxytocin levels.
  • Assessment of empathy, depression, and anxiety using validated questionnaires; MRI for hypothalamic damage grading.

Main Results:

  • CP patients did not show lower overall baseline oxytocin, but levels were reduced in those with hypothalamic damage.
  • All CP patients exhibited a blunted oxytocin release in response to exercise compared to controls.
  • Higher baseline oxytocin correlated with increased trait anxiety; blunted oxytocin release linked to higher state anxiety.

Conclusions:

  • Oxytocin deficiency is unmasked by exercise-induced stimulation in CP patients, particularly those with hypothalamic damage.
  • Baseline and stimulated oxytocin levels may differentially influence affective states like anxiety.
  • Findings suggest considering oxytocin's complex role in CP patient care and potential therapeutic substitution paradigms.